Tweet
The Utah People's Post
<img alt="" height="1" width="1" />
Failed Study on Medtronic Hypertension Product Won't End Work
Businessweek
Medtronic Inc. (MDT:US) isn't giving up on a new approach to treat hypertension with a device designed to sear the nerves that spur high blood pressure, even though the first rigorous trial of the method failed to help patients, company officials said.
Novel therapy fails for lowering blood pressureBusiness Recorder
Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo ...TCTMD
SYMPLICITY HTN-3 presented: Renal denervation misses primary efficacy ...Healio
MarketWatch -KFGO -Wall Street Journal
all 33 news articles »
More...